This Extension of Time was filed at the USPTO Trademark Trial and Appeal Board (TTAB) on August 04, 2022 and assigned serial number 88296649 by the TTAB.

Plaintiff:
Iovance Biotherapeutics, Inc. represented by CARLA B. OAKLEY of MORGAN, LEWIS & BOCKIUS LLP.

Defendant:
CytomX Therapeutics, Inc. represented by STEPHANIE K. WADE of SUGHRUE MION, PLLC.
Trademark Information: IOVONDA – US Trademark Serial Number 88296649
View Trademark Status at USPTO
View Trademark Documents at USPTO

Prosecution History:
August 04, 2022 – FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE
August 04, 2022 – EXT GRANTED
October 25, 2022 – ABANDONMENT NOTED; EXT TERMINATED
October 25, 2022 – TERMINATED
View this TTAB Proceeding at USPTO

About Select IP
Select IP Law Corporation monitors TTAB proceedings that have been instituted. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.